top of page

Wilms Foundation Research News

young-boy-in-hospital-with-parent-with-wilms-tumor.jpeg

What's on this page:

 

Stay up to date with the latest Wilms tumor research news, childhood kidney cancer studies, clinical research, treatment advances, and scientific developments from around the world. Explore research updates covering Wilms tumor biology and genetics, diagnosis and treatment, clinical trials, relapsed and high-risk disease, survivorship and long-term outcomes, alongside international research collaborations dedicated to improving understanding, care, and outcomes for children affected by Wilms tumor.

Stay Up-to-Date with the Latest Wilms Tumor Research News

 

Welcome to the Wilms Cancer Foundation Research News page, your source for the latest Wilms tumor research, childhood kidney cancer studies, clinical developments, treatment advances, and scientific discoveries from around the world. This research centre provides updates on studies and developments across the Wilms tumor research landscape, including tumor biology, genetics, biomarkers, diagnosis, treatment, clinical trials, relapse, high-risk disease, survivorship, late effects, and long-term outcomes.

​

As a global organization dedicated specifically to Wilms tumor and childhood kidney cancer, the Wilms Cancer Foundation works to strengthen access to trusted knowledge, encourage research collaboration, and connect families, healthcare professionals, researchers, and advocates with important developments in pediatric renal tumor research. Through the Global Wilms Tumor Initiative™ (GWTI), the Wilms Tumor Knowledge Index™ (WTKI), and collaboration with healthcare institutions, researchers, international organizations, and childhood cancer partners, the Foundation supports the exchange of knowledge that can contribute to better understanding and improved outcomes for children affected by Wilms tumor worldwide.

​

This page features Wilms tumor research news, published studies, clinical research, treatment developments, scientific discoveries, international research collaborations, and emerging areas of investigation relevant to childhood kidney cancer. Follow advances in understanding how Wilms tumors develop, how risk and treatment may be refined, why some tumors relapse or become more difficult to treat, and how research is helping improve surveillance, survivorship, and long-term care. Stay informed about the evolving Wilms tumor research landscape and the international scientific efforts working toward more effective, precise, and equitable care for every child affected by Wilms tumor.

DNA repair genes may influence Wilms tumor risk in children

A new genetic study investigates whether variations in genes responsible for repairing damaged DNA may influence a child's susceptibility to Wilms tumor. The findings provide further insight into biological mechanisms that may contribute to childhood kidney cancer and could help guide future research into genetic risk factors.

​

Gene - November 15th, 2026

Researchers examined 416 children with Wilms tumor and 936 children without the disease across six medical centers in eastern China. The study investigated 20 genetic variations within the base excision repair pathway, which helps protect cells from DNA damage. The findings suggest that certain genetic differences may be associated with Wilms tumor susceptibility, although further research is needed to confirm these associations and determine their clinical significance.

Read more about DNA repair genes and Wilms tumor risk

​

New research identifies metabolic changes in Wilms tumor

A new study explores how changes in cellular metabolism may contribute to the development of Wilms tumor, offering fresh insights into the biological processes that drive childhood kidney cancer. By combining advanced protein and metabolite analysis, researchers identified abnormalities in several important metabolic pathways that could help inform future approaches to tumor classification and targeted treatment.

​

Scientific Reports - November 10th, 2026

Researchers examined blood samples from 36 children with Wilms tumor alongside 36 healthy controls, as well as tumor and surrounding kidney tissue samples. Their findings revealed significant differences in metabolic activity and protein expression, particularly within pathways responsible for cellular energy production. Although preliminary, the results highlight potential molecular biomarkers and new directions for investigating how Wilms tumors develop, with possible implications for more personalized diagnosis and treatment strategies.

Read more about metabolic discoveries in Wilms tumor research

​

Long-term kidney health after bilateral Wilms tumor treatment

A multicenter study investigates long-term survival and kidney function in children diagnosed with multifocal bilateral Wilms tumor, a rare form of childhood kidney cancer involving multiple tumors in both kidneys. The research highlights the importance of balancing effective cancer treatment with the preservation of healthy kidney tissue.

​

Journal of Pediatric Urology - October 2026

Researchers examined 56 children treated for multifocal bilateral Wilms tumor, with a median follow-up of six years. The study reported five-year overall survival of 86.8%, while approximately 32% of patients experienced impaired kidney function. The findings identified surgical factors associated with renal impairment and suggest that carefully planned kidney-sparing procedures may help preserve long-term kidney function in selected patients.

Read more about long-term kidney health after bilateral Wilms tumor

​

Lymph node sampling and outcomes in Wilms tumor

A large Children's Oncology Group analysis investigates the importance of lymph node assessment during Wilms tumor surgery and whether the number and proportion of positive nodes can provide additional prognostic information.

​

Annals of Surgery - September 10th, 2026

Lymph node evaluation is an important component of accurate Wilms tumor staging. The study analyzed more than 2,000 children with Stage I–III favorable-histology disease, adding to evidence that careful and standardized lymph node sampling remains an important part of Wilms tumor surgery.

Read more about lymph node sampling and Wilms tumor outcomes

​

Wilms tumor: Diagnosis and updates

This review walks through how pathologists identify Wilms tumor today, covering its typical appearance under the microscope and the range of variant forms it can take. It also looks at the growing list of molecular and histological markers used to classify tumors and support increasingly precise risk assessment.

​

Diagnostic Pathology - September 2nd, 2026

Although Wilms tumor is the most common malignant kidney tumor in childhood, it remains uncommon overall and can vary considerably from one case to another. The authors discuss the conditions that must be distinguished from Wilms tumor and the roles of histology, immunohistochemistry and molecular testing in establishing an accurate diagnosis.

Read more about Wilms tumor pathology and diagnosis updates

​

PRAME-specific T-cell therapy in advanced pediatric nephroblastoma

A new report describes the use of PRAME-targeted T-cell therapy in a child with advanced Wilms tumor, providing an early indication of how highly targeted immunotherapy might eventually contribute to treatment of difficult-to-treat disease.

​

The New England Journal of Medicine - August 13th, 2026

In this individual patient, treatment produced a 69% reduction in tumor volume, with molecular, metabolic and histological evidence of complete remission reported at 200 days. This is a single-patient report rather than evidence of an established treatment, but the response provides an important proof-of-concept for further investigation of targeted cellular therapies in Wilms tumor.

Read more about PRAME T-cell therapy and Wilms tumor

​

DNA methylation and transcriptomic profiles reveal new insights into Wilms tumor

Researchers have combined epigenetic and gene-expression analysis to investigate molecular characteristics that may contribute to Wilms tumor development and potentially improve tumor classification.

​

International Journal of Cancer - July 30th, 2026

The study examined DNA methylation alongside gene-expression patterns to identify deregulated genes and epigenetic processes relevant to Wilms tumor biology. The findings add to growing evidence that molecular characteristics could complement conventional pathology when researchers classify tumors and investigate differences in risk.

Read more about DNA methylation and Wilms tumor epigenetics

​

New genetic risk model could help predict Wilms tumor outcomes

A new study investigates whether the activity of specific immune-related genes could help identify children with Wilms tumor who face different risks of disease progression or poorer outcomes. The research forms part of growing efforts to develop molecular tools that may eventually complement traditional cancer risk assessment.

​

Medicine - July 24th, 2026

Researchers analyzed publicly available tumor gene-expression and clinical data to identify four immune-related genes associated with patient survival: EGF, TDGF1, LTB4R and HLA-DMB. These genes were incorporated into an experimental prognostic model designed to distinguish between higher- and lower-risk patients. Although the findings suggest potential for more personalized risk assessment, the model requires further independent validation before it could be considered for clinical use.

Read more about genetic risk prediction in Wilms tumor

​

Kidney-sparing surgery succeeds in a nine-day-old newborn with Wilms tumor

An extraordinary medical case describes successful kidney-sparing surgery in a newborn diagnosed with Wilms tumor at just nine days old. The report demonstrates how carefully selected patients may benefit from surgical approaches that remove cancerous tissue while preserving healthy kidney function, even at an exceptionally young age.

​

Children - July 22nd, 2026

The authors describe the youngest reported patient with unilateral, non-syndromic Wilms tumor successfully treated using nephron-sparing surgery rather than complete removal of the affected kidney. At 18 months of follow-up, the child remained asymptomatic, with evidence of preserved function in both kidneys. Although this represents a single patient, the outcome highlights the potential importance of individualized surgical planning and long-term renal preservation.

Read more about kidney-sparing surgery in a newborn with Wilms tumor

​

Wilms tumor care in Yemen: New research highlights treatment outcomes

A new study provides valuable insight into the diagnosis, treatment and outcomes of children with Wilms tumor in Sana'a, Yemen. Research from conflict-affected and resource-constrained settings remains limited, making studies of this kind important for understanding childhood cancer care across different healthcare environments.

​

Cureus - July 14th, 2026

Researchers examined 14 children diagnosed with Wilms tumor, assessing clinical presentation, disease stage, treatment and short-term outcomes. Thirteen children achieved complete remission during the reported follow-up period, while one experienced relapse and subsequently died. Although the study involved a small patient population and relatively short follow-up, it adds to international evidence surrounding Wilms tumor treatment and emphasizes the importance of expanding access to specialist pediatric oncology care.

Read more about Wilms tumor treatment and outcomes in Yemen

​

When can surgeons preserve part of a kidney affected by Wilms tumor?

A new review examines whether kidney-sparing surgery could be appropriate for selected children diagnosed with a single Wilms tumor affecting one kidney. Although complete kidney removal remains the standard approach for many patients, advances in surgical techniques are encouraging researchers to explore opportunities to preserve healthy kidney tissue.

​

Journal of Kidney Cancer - July 8th, 2026

The authors review existing research alongside two clinical cases involving nephron-sparing surgery for unilateral Wilms tumor. Their analysis considers factors including tumor size, location, surgical margins, response to preoperative chemotherapy and preservation of healthy kidney tissue. The findings suggest that carefully selected patients may benefit from kidney-preserving approaches, while emphasizing that complete cancer removal and accurate staging remain essential priorities.

Read more about kidney-sparing surgery options for Wilms tumor

​

AI-generated 3D models could improve surgical planning for Wilms tumor

Researchers have developed an artificial intelligence system capable of identifying kidneys and tumors in MRI scans and helping convert the images into detailed three-dimensional models. The technology could assist pediatric surgeons in understanding complex tumor anatomy and preparing for kidney-preserving operations.

​

Journal of Pediatric Surgery - July 2026 (published online April 25th)

The researchers developed their deep-learning system using imaging data from 56 patients before testing it prospectively in 10 additional children with Wilms tumor. Automated models were usable without correction in two patients, while the remaining cases required adjustments that generally took less than 15 minutes. The results demonstrate that AI-assisted 3D modeling can be incorporated into surgical planning workflows, although expert review remains important to ensure anatomical accuracy.

Read more about AI-generated 3D models for Wilms tumor surgery

​

New expert consensus outlines surgical approaches for Wilms tumor

Pediatric surgical specialists have published a consensus document outlining recommendations for the surgical management of unilateral Wilms tumor. The publication addresses important decisions surrounding tumor removal, surgical preparation, staging and the preservation of healthy kidney tissue.

​

World Journal of Pediatric Surgery - June 17th, 2026

Developed by specialist groups within the Chinese Medical Association, the consensus brings together published evidence and expert clinical recommendations. The document discusses decisions surrounding immediate surgery, preoperative chemotherapy, lymph node assessment and nephron-sparing techniques. The recommendations aim to support more consistent surgical decision-making and contribute to ongoing international efforts to improve treatment outcomes for children with Wilms tumor.

Read more about expert surgical recommendations for Wilms tumor

​

New review highlights advances in Wilms tumor and neuroblastoma research

A major review examines recent developments in the understanding, diagnosis and treatment of Wilms tumor and neuroblastoma. Although these childhood cancers differ in their biological origins and treatment approaches, ongoing research into both diseases is contributing to improvements in pediatric oncology.

 

Hematology/Oncology Clinics of North America - June 2026

The authors examine progress in understanding tumor biology and the development of increasingly risk-adapted treatment strategies. Molecular research, improved classification and advances in multidisciplinary care are helping specialists explore opportunities to tailor treatment more precisely to individual patients. The review provides an overview of important developments and continuing challenges in the management of these childhood cancers.

Read more about advances in Wilms tumor and neuroblastoma research

​

Can artificial intelligence diagnose Wilms tumor without expert oversight?

As artificial intelligence becomes increasingly capable of analyzing medical scans, specialists are examining how the technology should be integrated into childhood cancer diagnosis. A new commentary highlights both the potential benefits of AI imaging systems and the importance of maintaining experienced clinical oversight.

​

Brazilian Journal of Nephrology - June 2026

The authors respond to a systematic review and meta-analysis investigating AI-assisted differentiation of Wilms tumor from other kidney masses. While acknowledging promising diagnostic performance, they emphasize the importance of independent validation, clinical interpretation and patient safety. The commentary supports using artificial intelligence as an additional diagnostic tool rather than a replacement for radiologists and multidisciplinary pediatric oncology teams.

Read more about artificial intelligence and clinical oversight in Wilms tumor imaging

​

Single-nucleus RNA sequencing reveals Wilms tumor heterogeneity

Researchers have used single-nucleus RNA sequencing to examine Wilms tumor at the cellular level, revealing biological differences between cells that may not be apparent through conventional pathology alone.

​

JCI Insight - June 9th, 2026

The study examined the transcriptional characteristics of Wilms tumor cells and their relationship to normal kidney development. Research of this kind is helping scientists understand the developmental origins and biological diversity of Wilms tumor and could eventually contribute to more precise tumor classification.

Read more about single-cell research in Wilms tumor

​

Bilateral Wilms tumor: Looking for the best surgical strategy

Researchers have examined how surgeons can balance cancer control with preservation of healthy kidney tissue in children whose Wilms tumor affects both kidneys.

​

Annals of Surgical Oncology - June 4th, 2026

The study analyzed 96 children with synchronous bilateral Wilms tumor treated within the SIOP 2001 framework. The authors support nephron-sparing surgery when technically possible and emphasize individualized planning based on tumor anatomy, response to chemotherapy and vascular involvement.

Read more about bilateral Wilms tumor surgery

​

Prognostic molecular biomarkers in Wilms tumors

A major systematic review brings together evidence surrounding molecular biomarkers that could help identify children with Wilms tumor who face different risks of relapse or poorer outcomes.

​

JCO Precision Oncology - May 18th, 2026

The researchers reviewed evidence involving molecular abnormalities including 1q gain, 1p and 16q changes, TP53, MYCN, WT1, SIX1/SIX2 and several microRNA-processing genes. Better understanding of these biomarkers could contribute to increasingly precise risk-adapted treatment strategies.

Read more about Wilms tumor biomarkers and genetic risk

​

Scientists identify 71 previously unreported genetic variants in Wilms tumor

New genomic research has identified 71 previously unreported genetic variants across 16 genes, expanding scientists' understanding of the molecular changes associated with Wilms tumor. The findings may provide new directions for investigating how childhood kidney tumors develop and why their biological characteristics can differ.

​

Journal of the Indian Association of Pediatric Surgeons - May 5th, 2026

Researchers used whole-genome sequencing and computational analysis to investigate genetic alterations in Wilms tumor tissue. They identified variants involving genes including KRT18, CNN2, MUC16, MUC19 and FCGBP, several of which may participate in biological processes associated with tumor development. The findings expand the catalog of genetic changes identified in Wilms tumor, although further functional research is necessary to establish their roles and potential clinical significance.

Read more about newly identified genetic variants in Wilms tumor

​

New genetic study investigates inherited Wilms tumor risk in children

A multicenter study examines genetic and epigenetic abnormalities that may predispose children to developing Wilms tumor. The findings contribute to growing knowledge of inherited cancer susceptibility and may help researchers better understand which children could benefit from genetic evaluation and additional surveillance.

​

International Journal of Molecular Sciences - May 1st, 2026

Researchers investigated 134 children with Wilms tumor in Russia, including patients with tumors affecting one or both kidneys. Genetic or epigenetic abnormalities associated with cancer predisposition were identified in 32 patients, representing approximately 24% of the study population. The findings highlight the importance of genetic assessment in selected patients and provide additional evidence linking molecular abnormalities with bilateral disease and other clinical characteristics.

Read more about inherited risk and genetic testing for Wilms tumor

​

Artificial intelligence helps identify Wilms tumor and neuroblastoma on CT scans

A new study explores how artificial intelligence could assist doctors in identifying childhood abdominal tumors through CT imaging. The researchers developed a deep-learning system designed to locate suspicious masses and support the distinction between Wilms tumor and neuroblastoma, two cancers that can sometimes present with overlapping imaging characteristics.

​

Life - April 13th, 2026

The researchers trained and evaluated an AI model using 3,553 CT images, including images containing tumors and those without identifiable lesions. In the study's test dataset, the model achieved 95.3% accuracy in distinguishing tumor-containing images from background images and demonstrated promising performance in locating and classifying lesions. Although the results highlight the potential of AI-assisted imaging, further independent clinical testing is needed to determine its reliability for diagnosing individual patients.

Read more about AI-assisted diagnosis of Wilms tumor

​

Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor

Researchers have identified biological changes that may help explain why some favorable-histology Wilms tumors develop resistance to chemotherapy, potentially revealing new targets for future treatment research.

​

Cell Reports - March 24th, 2026

Using laboratory models and molecular analysis, researchers found evidence that resistant Wilms tumor cells can undergo developmental reprogramming and acquire more stem-like characteristics. The study identified changes involving genes and pathways including LIN28B and ABCB1, providing new insight into the biology of chemotherapy-resistant disease.

Read more about chemotherapy resistance in Wilms tumor

​

Residual blastema as a predictor of Wilms tumor outcomes

Research using SIOP WT 2001 data investigates whether the absolute amount of blastema remaining following preoperative chemotherapy could provide additional information about a child's risk.

​

Journal of Clinical Oncology - March 13th, 2026

Blastema is one of the characteristic cellular components of Wilms tumor. Measuring how much viable blastema remains following chemotherapy could potentially refine current histological risk classification and help researchers better identify children at increased risk of recurrence.

Read more about residual blastema and Wilms tumor prognosis

​

New research explores why immunotherapy remains challenging in Wilms tumor

A comprehensive review investigates why immunotherapy has not yet achieved the same level of success in Wilms tumor as in certain other cancers. Researchers are examining how the tumor's surrounding cellular environment affects the immune system's ability to recognize and attack cancer cells.

 

Cancers - March 11th, 2026

The authors examine the immune characteristics of Wilms tumor, including mechanisms that may allow cancer cells to evade immune detection and resist treatment. They discuss emerging approaches such as immune checkpoint inhibition, targeted antibodies and cellular immunotherapies. Although these treatments remain under investigation for Wilms tumor, improved understanding of tumor–immune interactions may help identify new therapeutic targets and support future clinical research.

Read more about immunotherapy research in Wilms tumor

​

Kidney-sparing surgery succeeds in a complex case of bilateral Wilms tumor

A new case report describes a challenging surgical approach in a child with advanced bilateral Wilms tumor whose tumors began growing again during chemotherapy. The report demonstrates how specialized surgical techniques may allow doctors to remove cancerous tissue while preserving functioning portions of both kidneys.

​

Frontiers in Pediatrics - February 26th, 2026

The authors describe a five-year-old girl with Stage V Wilms tumor involving both kidneys and suspected extension to the liver capsule. Following an initial response to chemotherapy, the tumors demonstrated renewed growth, requiring complex surgical intervention. Surgeons performed bilateral partial nephrectomies together with removal of the affected liver capsule. The patient was subsequently reported to be disease-free, highlighting a potential kidney-preserving option in selected complex cases while reinforcing the need for long-term monitoring.

Read more about kidney-sparing surgery in complex bilateral Wilms tumor

​

Long-term effects of modern Wilms tumor treatment

A major review examines the long-term health effects that can follow successful Wilms tumor treatment and considers how follow-up can be tailored to the treatments an individual survivor received.

​

Nature Reviews Urology - January 26th, 2026

Potential late effects include chronic kidney disease, cardiovascular disease, infertility and second primary cancers. The authors emphasize the importance of understanding which survivors are most vulnerable to particular treatment-related complications so that long-term monitoring and survivorship care can be better individualized.

Read more about Wilms tumor late effects and survivorship

​

New research examines relapsed Wilms tumor in resource-limited healthcare settings

A study from Pakistan investigates the challenges of treating children whose Wilms tumor returns or continues to progress despite initial treatment. The findings offer insight into survival outcomes and the factors that may influence treatment success in resource-constrained healthcare environments.

 

Cureus - January 21st, 2026

Researchers reviewed the records of 452 children treated for Wilms tumor at a specialist cancer center in Pakistan. Of these patients, 58 experienced disease relapse or progression, representing approximately 13% of the study population. The study examines clinical factors associated with outcomes following treatment failure and highlights the difficulties of managing recurrent disease. Its findings contribute to international research aimed at improving treatment strategies and strengthening childhood cancer services in resource-limited settings.

Read more about relapsed Wilms tumor outcomes in resource-limited settings

​

New evidence supports kidney-sparing surgery for selected children with bilateral Wilms tumor

A systematic review and meta-analysis examines the safety and effectiveness of nephron-sparing surgery in children diagnosed with Wilms tumor affecting both kidneys. The research investigates whether preserving healthy kidney tissue can help reduce the risk of long-term kidney complications while maintaining effective cancer treatment.

 

Health Science Reports - January 2026 (first published December 29th, 2025)

Researchers combined evidence from 13 studies involving 749 children who underwent kidney-sparing procedures for bilateral Wilms tumor. The analysis reported encouraging measures of preserved kidney function, with relatively low rates of dialysis and transplantation. However, survival outcomes varied considerably across studies, and differences in patient populations and treatment approaches limit direct comparisons. The authors conclude that kidney-sparing surgery is an important option for selected patients while emphasizing the need for stronger prospective evidence.

Read more about kidney-sparing surgery in bilateral Wilms tumor

​

Researchers examine rare liver and platelet complications during Wilms tumor treatment

A long-term clinical study investigates hepatopathy-thrombocytopenia syndrome, a rare complication involving liver abnormalities and reduced platelet levels in children receiving treatment for Wilms tumor. The researchers also examined disease recurrence and other treatment-related complications over a 20-year period.

​

Pediatrics & Neonatology - January 2026 (published online May 23rd, 2025)

Researchers reviewed the medical records of 23 children treated for Wilms tumor at a specialist hospital in Taiwan. Two patients developed hepatopathy-thrombocytopenia syndrome during treatment, while three experienced disease relapse during follow-up. All patients survived during the study's observation period, although one continued to experience recurrent disease. The findings emphasize the importance of monitoring treatment complications and maintaining appropriate long-term follow-up, while the small study does not establish the syndrome as a predictor of relapse.

Read more about liver and platelet complications in Wilms tumor

​​

 

Load More

More News & Media

Stay up to date with the latest news, international partnerships, programme launches, conference participation, press releases, and global developments from the Wilms Cancer Foundation as we work with leading organizations to improve outcomes for children diagnosed with Wilms tumor worldwide.

Read more about News & Media

​​​

Press Releases

Browse the latest official announcements from the Wilms Cancer Foundation, including new partnerships, programme launches, international initiatives, research collaborations, advocacy activities, and organizational milestones.

Explore the latest news at the Wilms Cancer Foundation

​

WHO, GICC & CureAll Announcement

Learn how the Wilms Cancer Foundation supports and works with the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC), and the CureAll Framework through education, advocacy, international collaboration, and healthcare capacity building.

Read more about the WHO (GICC & CureAll) Partnership Announcement with the WCF

​​

St. Jude Collaboration Announcement

Find out how the Wilms Cancer Foundation is collaborating with St. Jude Children's Research Hospital to strengthen international education, healthcare professional engagement, and global initiatives supporting children with Wilms tumor.

Read more about the international St. Jude Collaboration with the Wilms Cancer Foundation

​

WHO Global Status Report on Cancer 2026 Announcement

Explore the Foundation's contribution to the WHO Global Status Report on Cancer 2026 and learn how our expertise is helping support international efforts to improve childhood cancer care worldwide.

Read more about the WHO Global Status Report on Cancer 2026

​

Wilms Tumor WebApp™ Launch

Discover the launch of the Wilms Tumor WebApp™, an innovative digital platform designed to provide parents, healthcare professionals, researchers, and students with free access to trusted, evidence-based information and educational resources.

Read more about the Wilms Tumor WebApp™ Launch

​

Wilms Tumor Ai™ Launch

Learn about the launch of Wilms Tumor Ai™, an intelligent educational support platform that helps families and healthcare professionals quickly access reliable information about Wilms tumor, treatment, survivorship, and global resources.

Read more about Wilms Tumor Ai™ and its impact on Wilms care

​​​

Conference News

Keep up to date with the Foundation's participation in international pediatric oncology conferences, scientific meetings, educational events, and presentations that help advance global collaboration and knowledge sharing.

Read more about the latest Conference News​

Wilms tumor Symptoms

Wilms tumor symptoms may include abdominal swelling, stomach pain, blood in the urine, fatigue, fever, and other early warning signs of childhood kidney cancer.

Help Improve Outcomes for Children Worldwide

 

Support the Wilms Cancer Foundation's work in childhood cancer awareness, education, survivorship support, psychosocial care, and global advocacy. Together we can help improve access to trusted information, strengthen early diagnosis initiatives, and support children and families affected by Wilms tumor around the world.

 

For more information, guidance, and support resources please review the links provided below (and our website) or contact us directly. ​​

 

Home | Sitemap

​

Medical Hubs​

​​

Guide to Wilms tumor | Symptoms | Diagnosis & Staging | Treatment | Relapse | Long-term Effects | Survival Rates​

​

Nutrition | Statistics | Global Impact | Resources | Wilms Tumor Glossary

​​​​​

Community & Advocacy Hubs​

​

News | Donations

​​​

Corporate

​​

About Us | Contact | Privacy/ Terms & Conditions​​​​​ 

​​​​​​​

child-undergoing-wilms-tumor-nephrectomy.jpg

We would like to personally thank the following organizations for their previous and current support:

USA: Qualified 501(c)(3) Tax-Exempt Organization | EIN:98-3478827 

Wilms Cancer Foundation

|

© Copyright All Rights Reserved  

Canada: Registered Charity: 756261939 BC0001

  • Wilms tumor Videos of Patients Expereinces and Parent Interviews, Oncologists Training Tools, Treatm
  • Wilms tumor Photographs and Images of Patients Expereinces and Parent Interviews, Oncologists Traini
  • Wilms tumor Community Group of Patients Experiences and Parent Interviews, Oncologists Training Tool
  • Wilms tumor Links to Patients Expereinces and Parent Interviews, Oncologists Training Tools, Treatme
  • Wilms tumor News Posts of Patients Expereinces and Parent Interviews, Oncologists Training Tools, Tr
  • Wilms tumor Social Media Posts of Patients Expereinces and Parent Interviews, Oncologists Training T
  • Wilms tumor Posts of Patients Expereinces and Parent Interviews, Oncologists Training Tools, Treatme
Childhood Kidney Cancer Awareness colour designation is orange
© IdWorkz | Corporate Identity Management for the Wilms Cancer Foundation
bottom of page